Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors

Elnaz Nakhaei, Chan Woo Kim, Daiki Funamoto, Hikari Sato, Yuta Nakamura, Akihiro Kishimura, Takeshi Mori, Yoshiki Katayama

研究成果: ジャーナルへの寄稿記事

2 引用 (Scopus)

抄録

The use of imaging agents to visualize tumor cells is an advantageous technique to achieve a more efficient intraoperative diagnosis and effective debulking operations. Targeting of these agents to certain receptors that are overexpressed in cancer cells, such as the folate receptor, aids in tumor targeting. Several imaging probes have been developed using this strategy. However, these ligand-targeting cancer imaging probes are rapidly cleared during systemic delivery due to their small size, which compromises their biodistribution and circulation. Improving the detection of cancer requires higher accumulation and effective retention activities of imaging probes. Here we developed a new design for a folate-fluorophore conjugate that is modified with palmitoyl. Palmitic acid has a strong binding affinity with human serum albumin (HSA), which has the ability to form non-covalent host-guest complexes and has a blood half-life of 19 days. In this strategy, HSA is expected to serve as an endogenous nanocarrier for the designed probe in blood circulation. We hypothesized that via a reversible interaction with HSA, this simple palmitoyl modification on a folate-fluorophore conjugate can induce long blood circulation of the probe. Our folate-targeted probe could show longer blood circulation compared to the probe which lacks palmitoyl.

元の言語英語
ページ(範囲)1190-1195
ページ数6
ジャーナルMedChemComm
8
発行部数6
DOI
出版物ステータス出版済み - 1 1 2017

Fingerprint

Blood Circulation
Hemodynamics
Tumors
Folic Acid
Ligands
Imaging techniques
Serum Albumin
Neoplasms
Fluorophores
Palmitic Acid
Cells
Half-Life
Blood

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry

これを引用

Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors. / Nakhaei, Elnaz; Kim, Chan Woo; Funamoto, Daiki; Sato, Hikari; Nakamura, Yuta; Kishimura, Akihiro; Mori, Takeshi; Katayama, Yoshiki.

:: MedChemComm, 巻 8, 番号 6, 01.01.2017, p. 1190-1195.

研究成果: ジャーナルへの寄稿記事

Nakhaei, Elnaz ; Kim, Chan Woo ; Funamoto, Daiki ; Sato, Hikari ; Nakamura, Yuta ; Kishimura, Akihiro ; Mori, Takeshi ; Katayama, Yoshiki. / Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors. :: MedChemComm. 2017 ; 巻 8, 番号 6. pp. 1190-1195.
@article{a138b950f9784c1f8a16d58355cfd209,
title = "Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors",
abstract = "The use of imaging agents to visualize tumor cells is an advantageous technique to achieve a more efficient intraoperative diagnosis and effective debulking operations. Targeting of these agents to certain receptors that are overexpressed in cancer cells, such as the folate receptor, aids in tumor targeting. Several imaging probes have been developed using this strategy. However, these ligand-targeting cancer imaging probes are rapidly cleared during systemic delivery due to their small size, which compromises their biodistribution and circulation. Improving the detection of cancer requires higher accumulation and effective retention activities of imaging probes. Here we developed a new design for a folate-fluorophore conjugate that is modified with palmitoyl. Palmitic acid has a strong binding affinity with human serum albumin (HSA), which has the ability to form non-covalent host-guest complexes and has a blood half-life of 19 days. In this strategy, HSA is expected to serve as an endogenous nanocarrier for the designed probe in blood circulation. We hypothesized that via a reversible interaction with HSA, this simple palmitoyl modification on a folate-fluorophore conjugate can induce long blood circulation of the probe. Our folate-targeted probe could show longer blood circulation compared to the probe which lacks palmitoyl.",
author = "Elnaz Nakhaei and Kim, {Chan Woo} and Daiki Funamoto and Hikari Sato and Yuta Nakamura and Akihiro Kishimura and Takeshi Mori and Yoshiki Katayama",
year = "2017",
month = "1",
day = "1",
doi = "10.1039/c7md00102a",
language = "English",
volume = "8",
pages = "1190--1195",
journal = "MedChemComm",
issn = "2040-2503",
publisher = "Royal Society of Chemistry",
number = "6",

}

TY - JOUR

T1 - Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors

AU - Nakhaei, Elnaz

AU - Kim, Chan Woo

AU - Funamoto, Daiki

AU - Sato, Hikari

AU - Nakamura, Yuta

AU - Kishimura, Akihiro

AU - Mori, Takeshi

AU - Katayama, Yoshiki

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The use of imaging agents to visualize tumor cells is an advantageous technique to achieve a more efficient intraoperative diagnosis and effective debulking operations. Targeting of these agents to certain receptors that are overexpressed in cancer cells, such as the folate receptor, aids in tumor targeting. Several imaging probes have been developed using this strategy. However, these ligand-targeting cancer imaging probes are rapidly cleared during systemic delivery due to their small size, which compromises their biodistribution and circulation. Improving the detection of cancer requires higher accumulation and effective retention activities of imaging probes. Here we developed a new design for a folate-fluorophore conjugate that is modified with palmitoyl. Palmitic acid has a strong binding affinity with human serum albumin (HSA), which has the ability to form non-covalent host-guest complexes and has a blood half-life of 19 days. In this strategy, HSA is expected to serve as an endogenous nanocarrier for the designed probe in blood circulation. We hypothesized that via a reversible interaction with HSA, this simple palmitoyl modification on a folate-fluorophore conjugate can induce long blood circulation of the probe. Our folate-targeted probe could show longer blood circulation compared to the probe which lacks palmitoyl.

AB - The use of imaging agents to visualize tumor cells is an advantageous technique to achieve a more efficient intraoperative diagnosis and effective debulking operations. Targeting of these agents to certain receptors that are overexpressed in cancer cells, such as the folate receptor, aids in tumor targeting. Several imaging probes have been developed using this strategy. However, these ligand-targeting cancer imaging probes are rapidly cleared during systemic delivery due to their small size, which compromises their biodistribution and circulation. Improving the detection of cancer requires higher accumulation and effective retention activities of imaging probes. Here we developed a new design for a folate-fluorophore conjugate that is modified with palmitoyl. Palmitic acid has a strong binding affinity with human serum albumin (HSA), which has the ability to form non-covalent host-guest complexes and has a blood half-life of 19 days. In this strategy, HSA is expected to serve as an endogenous nanocarrier for the designed probe in blood circulation. We hypothesized that via a reversible interaction with HSA, this simple palmitoyl modification on a folate-fluorophore conjugate can induce long blood circulation of the probe. Our folate-targeted probe could show longer blood circulation compared to the probe which lacks palmitoyl.

UR - http://www.scopus.com/inward/record.url?scp=85021686382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021686382&partnerID=8YFLogxK

U2 - 10.1039/c7md00102a

DO - 10.1039/c7md00102a

M3 - Article

AN - SCOPUS:85021686382

VL - 8

SP - 1190

EP - 1195

JO - MedChemComm

JF - MedChemComm

SN - 2040-2503

IS - 6

ER -